drugset / Trial / NCT05582811
Effect of Riocigaut on Cerebral Vasodilation and Headache Induction in Healthy Volunteers
RandomizedCrossoverQuadruple-blindOther
Summary
This double-blind, randomized, placebo-controlled cross-over clinical trial aims to investigate the effects of riocigaut on cerebral arteries and headache inducing properties in healthy volunteers.
Timeline
- Start
- 2022-10-26
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riociguat | Other / unclassified | 2.5 mg | Oral |
| Subject | Riociguat | Other / unclassified | 5 mg | Oral |